Robert Lawrence Jr. Email and Phone Number
Washington, DC, US
Robert Lawrence Jr.'s Location
Washington DC-Baltimore Area, United States, United States
Robert Lawrence Jr.'s Contact Details
Robert Lawrence Jr. work email
- Valid
- Valid
- Valid
- Valid
Robert Lawrence Jr. personal email
n/a
Robert Lawrence Jr. phone numbers
About Robert Lawrence Jr.
An established biopharma executive, entrepreneur, team builder and creative problem solver with a track record of identifying unique opportunities and creating value. Founder of multiple specialty pharmaceutical companies, who has led the development of an array of innovative biopharmaceutical products in a wide array of therapy areas. Launched a successful global strategic consultancy and helped to support the development of hundreds of innovative therapeutic products. Deep expertise in the development of products designed to treat Rare Diseases, CNS, Mental Health, Cardio-Metabolic and other diseases and disorders.
Robert Lawrence Jr.'s Current Company Details
University Of Maryland, Baltimore (Umb)
View
Entrepreneur in Residence and Site Miner
Washington, DC, US
Robert Lawrence Jr. Work Experience Details
-
Entrepreneur In Residence And Site MinerUniversity Of Maryland, Baltimore (Umb)Washington, Dc, Us
-
Entrepreneur In Residence / Site MinerUniversity Of Maryland, Baltimore (Umb) Oct 2022 - PresentBaltimore, Maryland, UsWork directly with faculty and researchers within the University of Maryland, Baltimore system (the University of Maryland Medical School, Pharmacy School, etc.) and the officers of the University Technology Transfer Office to identify promising research projects and advance academic innovations by obtaining state and federal grants. Collaborate with TEDCO (Maryland’s state-sponsored economic development corporation) and the Maryland Life Science Venture Authority to support the Maryland Innovation Initiative (MII). Provide ongoing support to faculty entrepreneurs seeking to spin-out companies, acquire university IP, build company infrastructure and raise external capital.
-
Board TrusteeFocus (Fellowship Of Christians In Universities And Schools) Oct 2022 - PresentNew Canaan, Ct, UsStrategic Planning Task Force and Committee Member -
Founder / CeoTlc Therapeutics, Llc Aug 2016 - PresentTLC Therapeutics is a specialty pharmaceutical company focused on the commercialization of novel oral liquid reformulations of established medicines. Key milestones and accomplishments include: • Negotiated a multi-product licensing and manufacturing deal with Rosemont Pharmaceuticals providing TLC with exclusive rights to a portfolio of unique, oral liquid products, including TLC-100 (oral quetiapine suspension 20mg/ml). • Established an equity partnership with Camargo Pharmaceutical Services, the global 505(b)(2) regulatory consultancy • Developed regulatory/ labeling strategy and led cross-functional Product Development Team (PDT) in execution of development plan for TLC-100 (oral quetiapine suspension 20mg/ml);• Held multiple engagements with FDA; gained agreement on development program designed to maximize labeling differentiation of TLC-100• Developed IP strategy for TLC-100; Negotiated Agreement which assigned all intellectual property related to TLC-100 from Perrigo to TLC; Led patent prosecution resulting in grant of multiple US Patents (US # 9,993,486, #10,562,669 and #10,940,155 (Oral Quetiapine Suspension Formulations with Extended Shelf Life and Enhanced Bioavailability)); • Executed a Licensing and Commercialization Agreement with an established US specialty pharma company with the potential to generate >$20mil in future royalties to TLC Investors -
Founder / PresidentSalient Consulting, Llc Apr 2009 - PresentOwings Mills, Md, UsLaunched a full-service strategic consulting practice focused on facilitating and optimizing pivotal decisions defining brand strategy, pipeline optimization, lifecycle planning and marketing excellence; Developed a loyal client base of companies located in Europe and US ranging from mid-sized device manufacturers to traditional “big pharma” companies. Accomplishments included: • Developed the “Salient Toolkit” a decision-making framework and “best practices” implementation guide (i.e. ”how to develop” target product profiles, product positioning, etc.) designed to facilitate key cross-functional, trade-off decisions and ensure pragmatic decision-making involving R&D and commercial staff • Built extensive network of subcontractors, and sold and delivered more than 60 engagements generating more than $6.5M in revenue in first five (5) years of operations• Directly impacted the development and launch of over 30 products, including multiple blockbusters• Selected by big pharma company as a US and Global “Preferred Supplier” of strategic consulting services • Partnered extensively with appliedstrategic, ltd. a UK-based consultancy, and merged operations and books of business in 2014 -
Senior Vice PresidentPremier Consulting Jan 2022 - Dec 2023Morrisville, North Carolina, UsBuilding on successful foundation established at Camargo, I am responsible for expanding the set of strategic consulting solutions offered by Premier Consulting, as well as providing oversight and leading the execution for Premier Consulting's Commercialization Strategy solutions, which enable the organization's “concept to commercialization” offerings. Developed and implemented company-wide efforts and training designed to standardize the approach, execution and delivery of strategic consulting engagements. Resigned from full time employment in March 2023 but continue to provide ongoing services on a contract basis at request of company leadership. -
Senior Vice PresidentCamargo Pharmaceutical Services, Llc Aug 2020 - Dec 2021Responsible for developing and launching of a new line of commercially focused consulting services and for integrating commercial insights into Camargo's established product development solutions, fully enabling Camargo’s “concept to commercialization” offerings. Key accomplishments include: • Supported sales / BD efforts and generated >$1.5 million in new business signings and $1.2 million in revenue for commercial engagements within first 15 months. • Created training materials for new hires and existing scientific team members and provided detailed sales guides and ongoing support for Camargo’s business development and sales team.• Conducted multiple webinars and published blog posts and other enduring marketing materials designed to increase visibility and awareness of Camargo’s commercial strategy solutions • Played key role in supporting external due diligence requests and helped to ensure successful sale of Camargo to Premier Research, Inc for ~$130 million in cash. • Managed multiple workstreams designed to integrate Camargo’s operations into Premier Research’s infrastructure.
-
Chief Business OfficerAperta Biosciences May 2019 - 2020Aperta Biosciences is an emerging biopharma company focused on the development of novel treatments for Ocular Surface Disease (OSD), including blepharitis, ocular rosacea, meibomian gland dysfunction, and dry eye disease.
-
Founder / CeoTropical Disease Therapeutics, Llc Aug 2016 - 2020Tropical Disease Therapeutics, LLC was spun out of Chesapeake Therapeutics, LLC to advance a co-development partnership created to advance a novel form of triclabendazole, a well-known but non-FDA approved treatment for fascioliasis, a neglected tropical disease caused by liver flukes. Key achievements include:• Negotiated an exclusive collaboration agreement with Sequent, the sole global API manufacturer of triclabendazole• Developed regulatory strategy for TDT-01; Gained FDA agreement on abbreviated development plan comprised of small subset of non-clinical studies and a single pivotal Phase III safety and efficacy study• Oversaw the formulation of TDT-01 and development of manufacturing methods; Initiated stability protocol and initial dose-ranging toxicology studies• Established and validated clinical operations team located in endemic region of Bolivia; Gained approval for execution of clinical program from SEDES (Bolivian Ministry of Health) • Conducted an initial epidemiological screening study of over 5,000 school aged children in rural villages of the Bolivian Altiplano to assess the prevalence of fascioliasis • Discontinued TDT-01 program after FDA approval of Egaten®, a formulation of triclabendazole originally developed by Novartis and the subsequent grant of a Priority Review Voucher (PRV) to Novartis.
-
Founder / CeoChesapeake Therapeutics Jul 2014 - Apr 2019Created and managed a virtual specialty pharmaceutical company to develop a novel oral liquid formulation of methotrexate (CTx-001) to treat children with acute lymphoblastic leukemia, leading cause of pediatric cancer and juvenile rheumatoid arthritis. Accomplishments include: • Negotiated an equity-based services agreement with a CDMO to develop and manufacture CTx-001; Developed pilot formulation for CTx-001 • Applied for and received Orphan Designation from FDA for CTx-001• Raised $1.2 million in seed capital before competitive development program was identified• Discontinued CTx-001 program to focus on follow-on opportunities, ultimately resulting in the spinout and funding of Tropical Disease Therapeutics and TLC Therapeutics. Distributed equity in spinout organizations (TLC and TDT) to original investors in Chesapeake before terminating operations.
-
PartnerApplied Strategic 2013 - 2016London, GbResponsible for maintaining relationships with key clientele and overseeing the execution of global strategic consulting engagements. Accomplishments include: • Oversaw marketing and commercial strategy practice and expanded service offerings for appliedstrategic, leveraging the “Salient Toolkit”• Stepped away from day-to-day operations to pursue Chesapeake Therapeutics, LLC -
Marketing - Diabetes FranchiseMerck Feb 2007 - May 2009Rahway, New Jersey, UsOversaw a diverse group of responsibilities including: primary care promotion and sales, scientific strategy and advocacy, launch planning and management, lifecycle planning, and global commercial leadership for new formulations. Specific Accomplishments included: • Led the scientific leadership initiatives including medical education associated with the launch of JANUVIA and JANUMET. • Led cross-functional teams to develop the portfolio strategy and launch plan associated with major label updates for JANUVIA and JANUMET. • Led cross-functional team (including creative agency) to develop promotional programs and materials associated label updates. Provided oversight and direction to sales training and ensured 1800 primary care sales reps were trained on new materials at POA meetings • Franchise marketing point for new pipeline products; Co-led the creation of the global commercial development plan for JANUMET XR (approved in 2012). -
Market Research - Diabetes FranchiseMerck Sep 2004 - Mar 2007Rahway, New Jersey, UsKey member of extended marketing team responsible for informing strategic and physician promotion business decisions for Januvia®, a first-in-class anti-diabetes treatment. Conducted strategic analyses, designed and oversaw qualitative and quantitative market research projects and made key recommendations on launch strategy and tactics to executive marketing staff. Accomplishments include: • Led marketing team in reassessment of physician segmentation strategy and leverage points for Januvia®. Recommendations were incorporated into the US launch strategy. • Member of marketing sub-team responsible for the development of physician promotional material for Januvia®. Interfaced with creative agency and provided numerous contributions to the development of the branding hallmarks, messages and sales aid for Januvia®. • Oversaw multiple projects in support of the product positioning of Januvia®. Recommendations presented were ultimately accepted by global marketing team.
-
Marketing Management Associate - Field SalesMerck Aug 2003 - Sep 2004Rahway, New Jersey, UsSold Vytorin®, Zetia® and Singulair® to over 300 physician targets in the Philadelphia area. Consistently exceeded market share objectives for area targets by building and leveraging physician relationships and executing tactical plans.
-
Marketing Management Summer AsssociateMerck And Co. Jun 2002 - Sep 2002Rahway, New Jersey, UsConstructed, performed and analyzed primary market research on new segment of physician key opinion leaders. Developed comprehensive targeting and messaging strategy designed to activate thought leaders and increase advocacy of Vioxx in local networks.
-
AnalystWachovia Securities 1997 - 2001San Francisco, California, Us
Robert Lawrence Jr. Skills
Strategy
Market Research
Cross Functional Team Leadership
Start Ups
Business Strategy
Marketing Strategy
Management Consulting
Competitive Analysis
Pharmaceutical Industry
Management
Marketing
Segmentation
Market Analysis
Leadership
Strategic Planning
Biotechnology
Consulting
Commercialization
Strategic Consulting
Business Development
Global Marketing
Entrepreneurship
Diabetes
Product Management
Strategic Partnerships
Competitive Intelligence
Thought Leadership
Executive Management
Product Marketing
Go To Market Strategy
Workshop Facilitation
Mergers And Acquisitions
Medical Devices
Product Launch
Analytics
Positioning
Venture Capital
New Product Commercialization
New Business Development
Executive Decision Making
Building Relationships
Robert Lawrence Jr. Education Details
-
Duke University - The Fuqua School Of BusinessHealth Sector Management -
Wake Forest UniversityEnglish / History
-
Asheville School
Frequently Asked Questions about Robert Lawrence Jr.
What company does Robert Lawrence Jr. work for?
Robert Lawrence Jr. works for University Of Maryland, Baltimore (Umb)
What is Robert Lawrence Jr.'s role at the current company?
Robert Lawrence Jr.'s current role is Entrepreneur in Residence and Site Miner.
What is Robert Lawrence Jr.'s email address?
Robert Lawrence Jr.'s email address is ro****@****rch.com
What is Robert Lawrence Jr.'s direct phone number?
Robert Lawrence Jr.'s direct phone number is +121528*****
What schools did Robert Lawrence Jr. attend?
Robert Lawrence Jr. attended Duke University - The Fuqua School Of Business, Wake Forest University, Asheville School.
What skills is Robert Lawrence Jr. known for?
Robert Lawrence Jr. has skills like Strategy, Market Research, Cross Functional Team Leadership, Start Ups, Business Strategy, Marketing Strategy, Management Consulting, Competitive Analysis, Pharmaceutical Industry, Management, Marketing, Segmentation.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial